ASSOCIATED OF INFLAMMATORY MARKERS WITH SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETES - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

ASSOCIATED OF INFLAMMATORY MARKERS WITH SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETES

Description:

ASSOCIATED OF INFLAMMATORY MARKERS WITH SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 ... measured by immunoturbidometric method using commercialy available kit (Roche) ... – PowerPoint PPT presentation

Number of Views:695
Avg rating:3.0/5.0
Slides: 14
Provided by: mgsd
Category:

less

Transcript and Presenter's Notes

Title: ASSOCIATED OF INFLAMMATORY MARKERS WITH SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETES


1
ASSOCIATED OF INFLAMMATORY MARKERS WITH
SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETES
  • Caparevic Z, Kostic N, Ilic S, Dekleva M, Pencic
    B, Radojkovic I.
  • University Clinic for Internal Medicine, CHC"Dr
    Dragiša Mišovic"
  • Department of Endocrinology
  • School of Medicine, University of BELGRADE,
    SERBIA AND MONTENEGRO

2
Background
  • Accumulation, aggregation and oxidative
    modification of LDL are believed to play an
    important role in activation of inflammation.
  • Oxidized LDL (OxLDL) is associate with the
    proinflammatory C-reactive protein (CRP)
    suggested risk factors for atherosclerosis
    development.
  • Increased carotid intima-media thickness (IMK) is
    a surrogate marker of an early atherosclerosis

3
Aim
  • The aim of this study was to estimate relations
    between oxidized LDL (OxLDL), C-reactive protein
    (CRP) and common carotid intima-media thickness
    (IMT) in type 2 diabetic patients without
    coronary heart disease (CHD).

4
Methods Studied patients
  • 44 well controlled type 2 diabetic patients
    without CHD.
  • The control group was 27 healthy subjects.
  • ? None of the patients had a history of
    cerebrovascular or ischemic heart disease.
  • ? They were not treated with any other drugs
    except oral antidiabetics.

5
Methods-Biochemical measurements
  • Lipids profiles were measured by enzymatic
    methods.
  • OxLDL was determined by a commercially available
    sandwich ELISA (Mercodia).
  • Hs-CRP was measured using hemiluminiscent methods
    (Immulite-DPC).
  • HbA1c was measured by immunoturbidometric method
    using commercialy available kit (Roche).
  • Glucose were determined by enzymatic methods.
  • Common carotid artery intima-media thickness
    (IMT) was measured by ultrasonography (Hewlett
    Packard Image Point).

6
Results-Clinical parameters in diabetic patients
and controls
7
Results-Clinical parameters in diabetic patients
and controls
plt0,05 plt0,001
8
Levels of OxLDL was significantly increased in
diabetic patients compared to those of controls
Plt0.05
9
Levels of CRP was significantly increased in
diabetic patients compared to those of controls
Plt0.05
10
Correlation analysis revealed a significant
positive correlation between LDL and OxLDL
11
Correlation analysis revealed a significant
positive correlation between CRP and OxLDL
12
Correlation analysis revealed a significant
positive correlation between TgHDL and OxLDL
13
Conclusion
  • The results from our study showed that elevated
    levels of circulating oxLDL and CRP are
    associated with an early atherosclerosis
    development in type 2 diabetes.
  • The study authors also concluded that CRP and
    OxLDL measurements tended to identify different
    high-risk groups and that screening for both
    markers provided better prognostic information
    than screening for either alone.
Write a Comment
User Comments (0)
About PowerShow.com